In vitro and in vivo comparison of [ 3H](+)-PHNO and [ 3H]raclopride binding to rat striatum and lobes 9 and 10 of the cerebellum: A method to distinguish dopamine D 3 from D 2 receptor sites: A method to distinguish dopamine D 3 from D 2 receptor sites

Synapse

Volumn 65, Issue 6, 2011, Pages 467-478

  Kiss, Béla ^a   Horti, Ferenc ^a   Bobok, Amrita ^a  

^a GEDEON RICHTER LTD   (Hungary)

Author keywords

3H (+) PHNO; DA D 3 receptor; In vitro binding; In vivo binding; Rat cerebellum

Indexed keywords

DOPAMINE 2 RECEPTOR; DOPAMINE 2 RECEPTOR BLOCKING AGENT; DOPAMINE 3 RECEPTOR; NAXAGOLIDE; NAXAGOLIDE H 3; RACLOPRIDE; RACLOPRIDE H 3; SV 156; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; BINDING SITE; CEREBELLUM CORTEX; CONTROLLED STUDY; CORPUS STRIATUM; DRUG MECHANISM; IN VITRO STUDY; IN VIVO STUDY; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; BINDING, COMPETITIVE; CEREBELLUM; CORPUS STRIATUM; DOPAMINE AGONISTS; DOPAMINE ANTAGONISTS; LIGANDS; MALE; OXAZINES; RACLOPRIDE; RATS; RATS, WISTAR; RECEPTORS, DOPAMINE D2; RECEPTORS, DOPAMINE D3; STAINING AND LABELING; TISSUE CULTURE TECHNIQUES; TRITIUM;

EID: 79953266808     PISSN: 08874476     EISSN: 10982396     Source Type: Journal    
DOI: 10.1002/syn.20867     Document Type: Article

References (43)

1. Ariano MA, Sibley DR. 1994. Dopamine receptor distribution in the rat CNS: Elucidation using anti-peptide antisera directed against D1A and D3 subtypes. Brain Res 649: 95-110.
2. 3H]PD 128907, a putatively selective ligand for the D3 dopamine receptor, in rat brain: A receptor binding and quantitative autoradiographic study. Neuropsychopharmacology 18: 305-316.
3. Barik S, de Beaurepaire R. 1996. Evidence for a functional role of the dopamine D3 receptors in the cerebellum. Brain Res 737: 347-350.
4. Barili P, Bronzetti E, Ricci A, Zaccheo D, Amenta F. 2000. Microanatomical localization of dopamine receptor protein immunoreactivity in the rat cerebellar cortex. Brain Res 854: 130-138.
5. 3 receptor mediated effect? Prog Neuropsychopharmacol Biol Psychiatry 24: 39-49.
6. 2 receptor mRNA. Brain Res 564: 203-219.
7. Cheng Y, Prusoff WH. 1973. Relationship between the inhibition constant (Ki) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction. Biochem Pharmacol 22: 3099-3108.
8. 3 receptor in the rat brain. Neuroscience 65: 731-745.
9. 2/3 agonist PET radiotracer PHNO: Reproducibility in tracer characteristics and characterization of extrastriatal binding. Synapse 64: 301-312.
10. 3 dopamine receptor affinity of dopaminergic compounds in rat brain. Life Sci 62: 1825-1831.
11. Freedman SB, Patel S, Marwood R, Emms F, Seabrook GR, Knowles MR, McAllister G. 1994. Expression and pharmacological characterization of the human D3 dopamine receptor. J Pharmacol Exp Ther 268: 417-426.
12. 11C]-(+)-PHNO in rats using an intracerebral beta-sensitive system. Synapse 60: 172-183.
13. 3H]R(+)-7-OH-DPAT binding in the rat caudate-putamen. Neurochem Int 38: 31-42.
14. 3 agonist, induces c-fos mRNA expression in the rat cerebellum. Jpn J Pharmacol 89: 309-315.
15. Kohler C, Hall H, Ogren SO, Gawell L. 1985. Specific in vitro and in vivo binding of 3H-raclopride. A potent substituted benzamide drug with high affinity for dopamine D-2 receptors in the rat brain. Biochem Pharmacol 34: 2251-2259.
16. Kolasiewicz W, Maj J, Ossowska K. 2008. The involvement of cerebellar dopamine D3 receptors in locomotor activity of rats. J Neural Transm 115: 677-681.
17. 3 dopamine receptor: Neurobiology and potential clinical relevance. Pharmacol Rev 49: 231-252.
18. Levant B. 1998. Differential distribution of D3 dopamine receptors in the brains of several mammalian species. Brain Res 800: 269-274.
19. 3H]quinpirole: Identification of a discrete population of putative D3 receptors. Synapse 14: 90-95.
20. 3 receptors. Eur J Pharmacol 278: 243-247.
21. 3 receptor functions? Biochem Pharmacol 52: 511-518.
22. 3H]hydroxy-N, N-di-n-propyl-2-aminotetralin. Proc Natl Acad Sci USA 89: 8155-8159.
23. Martin GE, Williams M, Pettibone DJ, Zrada MM, Lotti VJ, Taylor DA, Jones JH. 1985. Selectivity of (+)-4-propyl-9-hydroxynaphthoxazine [(+)-PHNO] for dopamine receptors in vitro and in vivo. J Pharmacol Exp Ther 233: 395-401.
24. 125I]iodosulpride, a highly selective ligand. Science 228: 752-755.
25. McCormick PN, Kapur S, Graff-Guerrero A, Raymond R, Nobrega JN, Wilson AA. 2010. The antipsychotics olanzapine, risperidone, clozapine, and haloperidol are D2-selective ex vivo but not in vitro. Neuropsychopharmacology 35: 1826-1835.
26. 3H](+)PHNO. Synapse 17: 167-172.
27. Paxinos G, Watson C. 2007. The rat brain in stereotaxic coordinates, 6th ed. Amsterdam: Academic Press. p. 456.
28. 3H]-raclopride. Synapse 64: 624-633.
29. Rabiner EA, Slifstein M, Nobrega J, Plisson C, Huiban M, Raymond R, Diwan M, Wilson AA, McCormick P, Gentile G, Gunn RN, Laruelle MA. 2009. In vivo quantification of regional dopamine-D3 receptor binding potential of (+)-PHNO: Studies in non-human primates and transgenic mice. Synapse 63: 782-793.
30. Reavill C, Taylor SG, Wood MD, Ashmeade T, Austin NE, Avenell KY, Boyfield I, Branch CL, Cilia J, Coldwell MC, Hadley MS, Hunter AJ, Jeffrey P, Jewitt F, Johnson CN, Jones DN, Medhurst AD, Middlemiss DN, Nash DJ, Riley GJ, Routledge C, Stemp G, Thewlis KM, Trail B, Vong AK, Hagan JJ. 2000. Pharmacological actions of a novel, high-affinity, and selective human dopamine D(3) receptor antagonist. SB-277011-A. J Pharmacol Exp Ther 294: 1154-1165.
31. Ricci A, Vega JA, Mammola CL, Amenta F. 1995. Localisation of dopamine D3 receptor in the rat cerebellar cortex: A light microscope autoradiographic study. Neurosci Lett 190: 163-166.
32. 3H]-raclopride in the mouse brain in vivo. Naunyn-Schmiedeberg's Arch Pharmacol 340: 6-12.
33. Schotte A, Janssen PF, Bonaventure P, Leysen J. 1996. Endogenous dopamine limits the binding of antipsychotic drugs to D3 receptors in the rat brain: a quantitative autoradiography study. J Histochem 28: 791-799.
34. 3 receptor in schizophrenia and in antipsychotic drug actions. Brain Res Brain Res Rev 31: 277-287.
35. High receptors measured ex vivo are elevated in amphetamine-sensitized animals. Synapse 63: 186-192.
36. Seeman P, Ulpian C, Larsen RD, Anderson PS. 1993. Dopamine receptors labelled by PHNO. Synapse 14: 254-262.
37. high receptors. Synapse 58: 122-128.
38. 3) as a target for neuroleptics. Nature 347: 146-151.
39. 3 receptors on dopaminergic and nondopaminergic cell bodies and terminals. J Pharmacol Exp Ther 295: 1223-1231.
40. 2 receptor antagonists. Bioorg Med Chem 14: 815-825.
41. 125I]S(-)5-OH-PIPAT. Brain Res 778: 89-98.
42. 2 receptor occupancy is a common mechanism underlying animal models of antipsychotics and their clinical effects. Neuropsychopharmacology 25: 633-641.
43. 3H]propyl-2-aminotetralin and carbetapentane. J Neurochem 64: 700-710.